High expressions of miR-125b, miR-155, miR-1249-5p, miR-6737-5p, and miR-6819-5p in cancer cell-derived EVs have been shown to drive CAF differentiation in recipient fibroblasts via inhibition of the p53 pathway [101,102,115]. Here, TP53 is linked to cancer.